TNF and Miyoshi myopathy: A meta-analysis of TNF-α promoter polymorphisms association with MM risk validated a relationship of −308G>A and −238G>A with MM susceptibility, but not with survival and response to bortezomib/thalidomide treatment of MM patients (45).